Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma (PLoS ONE (2014) 9: 5 (e97406) DOI: 10.1371/journal.pone.0097406);Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Cheng, Chao ^a   Wan, Feng ^a   Liu, Lian ^b   Zeng, Fuqing ^a   Xing, ShI'An ^b   Wu, Xiaofei ^a   Chen, Xuepan ^a   Zhu, Zhaohui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; MESSENGER RNA; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; HOMEODOMAIN PROTEIN; MATRIX ATTACHMENT REGION BINDING PROTEIN; REPRESSOR PROTEIN; SATB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER STAGING; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; MITOSIS INHIBITION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1 GENE; WESTERN BLOTTING; CELL MOTION; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION;

BLOTTING, WESTERN; CADHERINS; CARCINOMA, RENAL CELL; CELL MOVEMENT; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX ATTACHMENT REGION BINDING PROTEINS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 84901309055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0301571     Document Type: Erratum

References (31)

1. Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, et al. (2013) Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One 8: e62823.
2. Xue YJ, Xiao RH, Long DZ, Zou XF, Wang XN, et al. (2012) Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. J Transl Med 10: 200.
3. Basso M, Cassano A, Barone C (2010) A survey of therapy for advanced renal cell carcinoma. Urol Oncol 28: 121-133.
4. Rini BI, Campbell SC, Escudier B (2009) Renal cell carcinoma. Lancet 373: 1119-1132.
5. Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, et al. (2008) Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res 14: 5579-5584.
6. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, et al. (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23: 2763-2771. (Pubitemid 46179466)
7. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, et al. (2007) A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 178: 429-434. (Pubitemid 47030487)
8. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353: 2477-2490. (Pubitemid 41770167)
9. Linehan WM, Zbar B (2004) Focus on kidney cancer. Cancer Cell 6: 223-228. (Pubitemid 39222035)
10. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288. (Pubitemid 44646290)
11. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645.
12. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193. (Pubitemid 351380252)
13. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42-51. (Pubitemid 36548789)
14. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, et al. (2007) Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9: 45-56. (Pubitemid 46024196)
15. Pavan Kumar P, Purbey PK, Sinha CK, Notani D, Limaye A, et al. (2006) Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol Cell 22: 231-243.
16. Notani D, Limaye AS, Kumar PP, Galande S (2010) Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator. Methods Mol Biol 647: 317-335.
17. Cheng C, Lu X, Wang G, Zheng L, Shu X, et al. (2010) Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 118: 855-863.
18. Lu X, Cheng C, Zhu S, Yang Y, Zheng L, et al. (2010) SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep 24: 981-987.
19. Tu W, Luo M, Wang Z, Yan W, Xia Y, et al. (2012) Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 32: 1064-1078.
20. Meng WJ, Yan H, Zhou B, Zhang W, Kong XH, et al. (2012) Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis 27: 143-150.
21. Shukla S, Sharma H, Abbas A, MacLennan GT, Fu P, et al. (2013) Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression. PLoS One 8: e53527.
22. Tang H, Wang J, Bai F, Zhai H, Gao J, et al. (2008) Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer. Cancer Invest 26: 60-67.
23. Chen F, Bai J, Li W, Mei P, Liu H, et al. (2013) RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma. PLoS One 8: e56241.
24. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, et al. (2003) An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 63: 5073-5083. (Pubitemid 37022647)
25. Han B, Luan L, Xu Z, Wu B (2013) Expression and biological roles of SATB1 in human bladder cancer. Tumour Biol 34: 2943-2949.
26. Chu SH, Ma YB, Feng DF, Zhang H, Zhu ZA, et al. (2012) Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med 10: 149.
27. Chen H, Takahara M, Oba J, Xie L, Chiba T, et al. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64: 39-44.
28. Seo J, Lozano MM, Dudley JP (2005) Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J Biol Chem 280: 24600-24609. (Pubitemid 40934548)
29. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
30. Sayan AE, Griffiths TR, Pal R, Browne GJ, Ruddick A, et al. (2009) SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci U S A 106: 14884-14889.
31. Fang Y, Wei J, Cao J, Zhao H, Liao B, et al. (2013) Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival. PLoS One 8: e62558.